RS

Rajiv Sahai Endlaw

Director Director DIN 00002027
DIN 00002027 First appointment Jan 2002 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2002
Shareholding value •••• Premium profile

About Rajiv Sahai Endlaw

Data last updated:

Rajiv Sahai Endlaw was a Director at Zenotech Laboratories Limited (2007–2008) and Director at Bharat Bhushan Finance & Commodity Brokers Limited (2002–2008). The companies operate in Pharma and Financial Services.

DIN 00002027
Primary Designation Director
Industry Pharma
First Appointment 24 Jan 2002

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zenotech Laboratories Limited L27100TG1989PLC010122
Director03 Oct 20071989₹44.60 Cr (FY 2025)Active
Director24 Jan 20021992₹29.3 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zenotech Laboratories Limited
Bharat Bhushan Finance & Commodity Brokers Limited
Premium access

Shareholding and investment profile for Rajiv Sahai Endlaw

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Sahai Endlaw

Rajiv Sahai Endlaw was first appointed on 24 Jan 2002 as Director at Bharat Bhushan Finance & Commodity Brokers Limited. The most recent appointment on record is 03 Oct 2007 at Zenotech Laboratories Limited.

Rajiv Sahai Endlaw held 2 earlier board appointments: Zenotech Laboratories Limited (Director, 03 Oct 2007 to 08 Apr 2008); Bharat Bhushan Finance & Commodity Brokers Limited (Director, 24 Jan 2002 to 08 Apr 2008).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available